Broad-Spectrum Antibiotic Use at the End of Life in Patients With Advanced Cancer
In this cohort study of patients with advanced cancer, broad-spectrum antibiotic use increased from 3 months to 2 weeks before death, suggesting that this may be a key period for optimizing use and aligning care with patient goals.
Authors
- Shin Hye Yoo (ORCID: https://orcid.org/0000-0001-7473-1082)
- Jin-Ah Sim (ORCID: https://orcid.org/0000-0002-3494-3002)
- Bhumsuk Keam (ORCID: https://orcid.org/0000-0001-8196-4247)
- Jeonghan Kim (ORCID: https://orcid.org/0000-0003-1695-9630)
- Dae Seog Heo
- Jieun Yu
Institutions
- Ewha Womans University (KR)
- Seoul National University (KR)
- Hallym University (KR)
- Seoul National University Hospital (KR)
- Sacred Heart Hospital (US)
- National Evidenc- based healthcare Collaborating Agency (KR)
- Hallym University Dongtan Sacred Heart Hospital (KR)
Publication Details
- Journal
- JAMA Network Open
- Published
- 2025-09-09
- DOI
- https://doi.org/10.1001/jamanetworkopen.2025.30980
- Citations
- 3
- Primary Topic
- Palliative Care and End-of-Life Issues
- Type
- article
- Field-Weighted Citation Impact
- 5.64
Funders
- Hallym University